Group 1 - The first extraordinary general meeting of shareholders for 2025 was held on July 30, 2025, in Hangzhou, Zhejiang Province [2][3] - The meeting was legally convened and presided over by the company's chairman, Tao Lingping, with the presence of legal counsel from Shanghai Dongfang Huayin Law Firm [2][6] - All resolutions presented at the meeting were passed with more than two-thirds of the voting rights held by attending shareholders [5][6] Group 2 - The company announced a downward adjustment of the conversion price for "Lingkang Convertible Bonds" from 8.00 yuan/share to 6.50 yuan/share, effective from August 1, 2025 [9][15] - The adjustment was triggered as the company's stock price had been below 85% of the current conversion price for at least 15 trading days within a 30-day period [11][14] - The average trading price of the company's stock over the 20 trading days prior to the meeting was 5.91 yuan/share, and the price on the previous trading day was 6.40 yuan/share [14]
灵康药业集团股份有限公司2025年第一次临时股东大会决议公告